Related Experiment Video

Updated: Sep 9, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

The current report on drug development focuses on "The new dimension" of cancer hallmarks

Sisca Ucche1, Yonika Arum Larasati2, Dini Maharani3

  • 1Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia.

Gene
|September 3, 2025
PubMed

Insights

New cancer drug discovery targets novel hallmarks like cell plasticity and microbiota. These small molecules aim to improve cancer treatment strategies and patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • Cancer remains a major global health challenge.
  • Understanding cancer development requires exploring new dimensions beyond traditional hallmarks.
  • Phenotypic plasticity, senescence, microbiota, and epigenetic reprogramming are emerging hallmarks of cancer.

Purpose of the Study:

  • To review pharmacological agents targeting novel cancer hallmarks.
  • To explore strategies for developing new cancer treatments.
  • To aid in overcoming challenges in cancer therapy.

Main Methods:

  • Review of literature on small molecule anticancer drugs.
  • Analysis of agents targeting phenotypic plasticity (dedifferentiation, blocked differentiation, trans-differentiation).
  • Categorization of drugs targeting senescent cells (senolytic and senomorphic agents).
  • Examination of microbial metabolites affecting chemotherapy efficacy.
  • Analysis of drugs targeting non-mutational epigenetic reprogramming (DNA methylation inhibitors, histone modification modulators, BET inhibitors, chromatin remodeling complexes).

Main Results:

  • Small molecule drugs targeting new dimension hallmarks are in preclinical and clinical development.
  • Specific microbial metabolites can influence chemotherapeutic efficacy.
  • Epigenetic modifiers represent a promising class of anticancer agents.

Conclusions:

  • Targeting novel cancer hallmarks offers new therapeutic avenues.
  • Pharmacological agents addressing phenotypic plasticity, senescence, microbiota, and epigenetics are crucial for future cancer treatment strategies.
  • This review contributes to developing innovative approaches for improved cancer patient outcomes.
Keywords:
CancerDrug developmentThe new dimension hallmarks of cancerTherapy

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509